STOCK TITAN

BioSig Technologies, Inc. - $BSGM STOCK NEWS

Welcome to our dedicated page for BioSig Technologies news (Ticker: $BSGM), a resource for investors and traders seeking the latest updates and insights on BioSig Technologies stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BioSig Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BioSig Technologies's position in the market.

Rhea-AI Summary
BioSig Technologies' subsidiary, BioSig AI Sciences, has been selected to join NVIDIA Inception, a program that supports companies revolutionizing industries with AI advancements. This partnership will provide engineering guidance, technical training, and exposure to the NVIDIA investment community. BioSig plans to leverage NVIDIA's resources to advance its AI medical device platform and identify transformative applications in healthcare.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.92%
Tags
partnership AI
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.03%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.08%
Tags
none
-
Rhea-AI Summary
Researchers from Cleveland Clinic presented data from three abstracts at Heart Rhythm 2023, highlighting the potential of an optimized radiofrequency ablation technique for pulmonary vein isolation (PVI) using BioSig Technologies' PURE EP™ platform. The studies showed that using unipolar signals for guidance improved lesion precision, reduced procedure time, and maintained accuracy compared to the current standard of using the Ablation Index™. The findings have implications for improving radiofrequency ablation techniques for atrial fibrillation treatment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.36%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.62%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.79%
Tags
management
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.88%
Tags
management
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.19%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.29%
Tags
none
BioSig Technologies, Inc.

Nasdaq:BSGM

BSGM Rankings

BSGM Stock Data

25.08M
6.29M
22.56%
11.41%
7.44%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
WESTPORT

About BSGM

biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.